Back
Capricor Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
74
CAPR
Capricor Therapeutics, Inc.
Last Price:
$27.75
Seasonality Move:
36.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAPR is experiencing slight buying pressure.
Capricor Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.82 | Buy |
| 20-day SMA: | 19.57 | Buy |
| 50-day SMA: | 11.53 | Buy |
| 200-day SMA: | 9.86 | Buy |
| 8-day EMA: | 26.04 | Buy |
| 20-day EMA: | 21.21 | Buy |
| 50-day EMA: | 14.52 | Buy |
| 200-day EMA: | 6.68 | Buy |
Capricor Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.25 | Buy |
| Relative Strength Index (14 RSI): | 72.85 | Buy |
| Chaikin Money Flow: | 40633 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.97 - 27.61) | Buy |
| Bollinger Bands (100): | (2.36 - 16.26) | Buy |
Capricor Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics, Inc. Stock
Is Capricor Therapeutics, Inc. Stock a Buy?
-
Capricor Therapeutics, Inc. share price is 27.81 while CAPR 8-day simple moving average is 26.82, which is a Buy signal.
-
The stock price of CAPR is 27.81 while Capricor Therapeutics, Inc. 20-day SMA is 19.57, which makes it a Buy.
-
Capricor Therapeutics, Inc. 50-day simple moving average is 11.53 while CAPR share price is 27.81, making it a Buy technically.
-
CAPR stock price is 27.81 and Capricor Therapeutics, Inc. 200-day simple moving average is 9.86, creating a Buy signal.
CAPR Technical Analysis vs Fundamental Analysis
Buy
74
Capricor Therapeutics, Inc. (CAPR)
is a Buy
Is Capricor Therapeutics, Inc. a Buy or a Sell?
-
Capricor Therapeutics, Inc. stock is rated a BuyThe current Capricor Therapeutics, Inc. [CAPR] share price is $27.81. The Score for CAPR is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Capricor Therapeutics, Inc. Stock Info
Market Cap:
1.3B
Price in USD:
27.81
Share Volume:
1.9M
Capricor Therapeutics, Inc. 52-Week Range
52-Week High:
40.37
52-Week Low:
4.30
Buy
74
Capricor Therapeutics, Inc. (CAPR)
is a Buy
Capricor Therapeutics, Inc. Share Price Forecast
-
What is the Capricor Therapeutics, Inc. stock price today?The Capricor Therapeutics, Inc. stock price is 27.81 USD today.
-
Will CAPR stock go up or go down?Capricor Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Capricor Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics, Inc. is not overvalued.
Is Capricor Therapeutics, Inc. Stock a Buy?
-
Capricor Therapeutics, Inc. share price is 27.81 while CAPR 8-day exponential moving average is 26.04, which is a Buy signal.
-
The stock price of CAPR is 27.81 while Capricor Therapeutics, Inc. 20-day EMA is 21.21, which makes it a Buy.
-
Capricor Therapeutics, Inc. 50-day exponential moving average is 14.52 while CAPR share price is 27.81, making it a Buy technically.
-
CAPR stock price is 27.81 and Capricor Therapeutics, Inc. 200-day simple moving average is 6.68, creating a Buy signal.
Fundamental Analysis of Capricor Therapeutics, Inc.
Is Capricor Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.61 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.06 per share, and an increase next year of $2.54 per share.
Technical Analysis of Capricor Therapeutics, Inc.
Should I short Capricor Therapeutics, Inc. stock?
-
CAPR Moving Average Covergence Divergence (MACD) indicator is 5.25, suggesting Capricor Therapeutics, Inc. is a Buy
-
Capricor Therapeutics, Inc. Relative Strength Index (RSI) is 72.85, which suggest Capricor Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Capricor Therapeutics, Inc. is (5.97 - 27.61), which suggest Capricor Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Capricor Therapeutics, Inc. is (2.36 - 16.26), which suggest Capricor Therapeutics, Inc. is a Buy
* Capricor Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.